Stay up to date with the latest news and announcements from NASCSA.
Posted 9/12/2021
The Food & Drug Administration (FDA) recognizes that there may be new opportunities to improve prescriber education through the Opioid Analgesic Risk Evaluation and Mitigation Strategy and ensure that the education is being delivered in a way that minimizes the burden on the healthcare...
Read More
Posted 9/9/2021
The New York Bureau of Narcotic Enforcement (BNE) is looking for a Deputy Director. The position is responsible for the administration and oversight of the following programs: New York State's Prescription Drug Monitoring Program, Office Prescription Program, Electronic Prescribing,...
Read More
Posted 9/6/2021
Join the National Association of State Controlled Substances Authorities (NASCSA) September 29, 2021 3-4 pm ET for an exclusive look at our new website being launched as a result of the generous contribution of MDScripts. Speakers: Theo Antoniou, Chief Technology Officer...
Read More
Posted 9/3/2021
On September 2, 2021 Regina LaBelle, Acting Director of National Drug Control Policy, presented to Congress the Biden-Harris Administration?s recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances...
Read More
Posted 8/13/2021
This is to inform you of changes to the Connecticut Prescription Monitoring and Reporting System (CPMRS) that will take place on September 1, 2021.
The CPMRS reporting requirements will be adding and modifying some required, situational, and not required fields in the ASAP 4.2A software...
Read More
Posted 8/13/2021
Beginning December 1, 2021, the Alabama Prescription Drug Monitoring Program (PDMP) will be adopting the latest reporting standard from the American Society for Automation in Pharmacy (ASAP). Please read the attached document that contains links to additional information, next steps, and contact...
Read More